While artificial intelligence (AI) technologies are showing a lot of promise, many technologies, including generative AI (GenAI), fell short of expectations this calendar year, exposing the gap between innovation and commercial use.
The struggle in getting a return on investment (ROI) from GenAI projects, the metaverse's lack of mainstream adoption, volatility around bitcoins, the slow uptake of consumer 5G, and limping smart city projects underscored the difficulty of moving from the pilot stage to implementing full-scale projects.
We shed light on the hurdles these technologies face and explore their chances of bouncing back.
GenAI: No Returns
Generative AI (GenAI) has shown immense potential since OpenAI's ChatGPT gained over 100 million users within two months of its launch in December 2022.
Unlike traditional machine learning (ML), which predicts data patterns, GenAI's foundational models and large language models (LLMs) learn the structure of various data types—text, images, proteins, DNA, etc.—to create new content through prompts in natural languages like English or Hindi.
Companies are fine-tuning tools like ChatGPT, Bing Chat, Gemini, and DALL-E 2 to cut costs in customer service, content creation, and more. However, most businesses remain cautious, testing these tools rather than deploying them at scale.
Challenges include hallucinations (generating false information and presenting it confidently as accurate), biases, intellectual property violations, high energy consumption, and uncertain returns on investment.
Goldman Sachs' April report, GenAI: Too Much Spend, Too Little Benefit?, questioned the $1 trillion investment in AI infrastructure without clear benefits.
Similarly, Gartner's July report predicts that 30% of GenAI projects will be discontinued by 2025 due to poor data quality and escalating costs, which range from $5 million to $20 million.
This story is from the December 26, 2024 edition of Mint Chennai.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 26, 2024 edition of Mint Chennai.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
End the year with music, art
A Mint guide to what's happening in and around your city
Do fashion collaborations give both brands an edge?
As more international brands look to partner with Indian creatives, a closer look at what will make these mergers truly meaningful
Purists Don't Want Bakers To 'Mess' With The Mince Pie
Some Brits believe jazzing up the festive treat, made of dried fruit and pastry, takes away its nostalgic value
How will US federal workers react to the wrath of DOGE?
They face hard choices. The US should heed past advice on reforms
Watch 'Industry': Delve into imaginary trading
This serial does what the film 'Wall Street' did. It reveals how grubby investment banking can be. But it also shows the power of money to bury hatchets and forge unlikely alliances
A manufacturing sector revival is a must to uplift our economy
India requires structural changes that go beyond cosmetic policy tweaks to address the real issues
Bridging the Insurance Gap for India's Self-Employed with Tech Solutions
Self-employed people struggle to access term insurance and other financial protections
CFA or CFP: What's Right for Your Financial Career Goal?
Exploring the career paths of CFA and CFP aspirants from diverse professional backgrounds
Simhavalokana 2024: What Mr. Market Taught
Step into the shoes of an investor to understand the thrills (and surprises) a roaring bull market churns out
Hospital room rent caps: How dual policies can affect claims?
My corporate insurance policy includes a room rent cap for hospital stays, while my individual insurance policy does not. Will staying in a higher-category room affect my claim?
